# Xinxiang Tuoxin Pharmaceutical Co. Ltd – FDA Inspection, Jun 6, 2019

Source: https://www.keypedia.com/records/fda_inspections/xinxiang-tuoxin-pharmaceutical-co-ltd/0ae3dd15-5ffc-4835-9b28-f8e6c64d85a0
Source feed: FDA_Inspections

> FDA inspection 1095514 of Xinxiang Tuoxin Pharmaceutical Co. Ltd, June 06, 2019. Classification: Official Action Indicated (OAI). Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1095514
- Company Name: Xinxiang Tuoxin Pharmaceutical Co. Ltd
- Inspection Date: 2019-06-06
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1155762 - 2021-10-22](https://www.keypedia.com/records/fda_inspections/xinxiang-tuoxin-pharmaceutical-co-ltd/506c413c-eb87-4092-9738-4bfe2d362ab4)
- [FDA Inspection 946143 - 2015-09-18](https://www.keypedia.com/records/fda_inspections/xinxiang-tuoxin-pharmaceutical-co-ltd/8f4ab3ea-e85e-4539-95af-bd65cfe2267f)
- FDA Inspection 754959 - 2011-11-03

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/yasamin-ameri/73021772-c960-4c65-aa30-cb490866ee58)

Company: https://www.keypedia.com/companies/xinxiang-tuoxin-pharmaceutical-co-ltd/ba373358-5a25-46e6-a497-d61d94d78862

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
